A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Clinical trial NCT06557265 · RECRUITING

Trial details

NCT number: NCT06557265
Sponsor: Nkarta, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis Primary Membranous Nephropathy

Start date: 2024-06-13
Primary completion: 2027-04-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.